4.8 Review

Anticancer cyclometalated complexes of platinum group metals and gold

Journal

COORDINATION CHEMISTRY REVIEWS
Volume 257, Issue 19-20, Pages 2784-2797

Publisher

ELSEVIER SCIENCE SA
DOI: 10.1016/j.ccr.2013.03.024

Keywords

Medicinal; Cyclometalated; Organometallic; Anticancer; Platinum; Palladium; Gold; Ruthenium; Iridium; Rhodium; Cancer; Cytotoxicity

Funding

  1. Spanish Ministerio de Economia y Competitividad
  2. FEDER [SAF2011-26611]
  3. Fundacion Seneca-CARM [08666/PI/08]
  4. European Union Seventh Framework Programme - Marie Curie COFUND (FP7) under UMU Incoming Mobility Programme ACTion (U-IMPACT) [267143]
  5. COST ACTION [CM1105]

Ask authors/readers for more resources

The clinical success of cisplatin and its derivatives has had an enormous impact on the discovery of novel metal-based drugs. Extensive studies have focused on the interaction of metal complexes with their potential targets. The array of organometallic compounds with useful anticancer activity has been significantly extended with respect to metals and structures. This review highlights recent exciting results in the field of cyclometalated C-N complexes and C-N C, C-N-N and C-N-S pincer complexes of platinum, palladium, gold, ruthenium, rhodium, and iridium with potential anticancer properties. (C) 2013 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available